Targeting the EphB4 receptor tyrosine kinase sensitizes HER2-positive breast cancer cells to Lapatinib.

Ding J, Yao Y, Huang G, Wang X, Yi J, Zhang N, Liu C, Wang K, Zhang Y, Wang M, Liu P, Ye M, Li M, Cheng H
Cancer Lett. 2020 Apr 10;475:53-64. doi: 10.1016/j.canlet.2020.01.032. Epub 2020 Jan 29. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.